Does Perioperative Systemic Therapy Represent the Optimal Therapeutic Paradigm in organ-confined, muscle-invasive Urothelial carcinoma?

Luca Scafuri1 Oncology Unit, Hospital ‘Andrea Tortora,’ ASL Salerno, Pagani, 84016, Italy;2 Associazione O.R.A., Somma Vesuviana, Naples, Italy

Antonella Sciarra3 Department of Experimental Medicine, University of Campania ‘Luigi Vanvitelli,’ Naples, NA, 80131, Italy

Felice Crocetto4 Department of Neurosciences, Reproductive Sciences & Odontostomatology, Federico II University, Naples, 80131, Italy

Matteo Ferro5 Division of Urology, European Institute of Oncology (IEO), IRCCS, Milan, 20099, Italy

Carlo Buonerba1 Oncology Unit, Hospital ‘Andrea Tortora,’ ASL Salerno, Pagani, 84016, Italy;2 Associazione O.R.A., Somma Vesuviana, Naples, ItalyCorrespondence[email protected]

Francesco Ugliano6 Department of Medicine & Health Science, University of Molise, Campobasso86100, Italy

Germano Guerra6 Department of Medicine & Health Science, University of Molise, Campobasso86100, Italy

Roberto Sanseverino7 Department of Urology, Umberto I Hospital, ASL Salerno, Nocera Inferiore, 84014, Italy

Giuseppe Di Lorenzo1 Oncology Unit, Hospital ‘Andrea Tortora,’ ASL Salerno, Pagani, 84016, Italy;2 Associazione O.R.A., Somma Vesuviana, Naples, Italy;6 Department of Medicine & Health Science, University of Molise, Campobasso86100, Italy

show all

Click to increase image sizeClick to decrease image size

Financial & competing interests disclosure

C Buonerba (in the last 3 years) has provided consulting to Ipsen. His Institution has received research funding from Sanofi, Astellas and AstraZeneca. C Buonerba serves as an editorial board member of Future Science OA. The authors have no other relevant affiliations or financial involvement with any organization or entity with a financial interest in or financial conflict with the subject matter or materials discussed in the manuscript apart from those disclosed.

No writing assistance was utilized in the production of this manuscript.

Does Perioperative Systemic Therapy Represent the Optimal Therapeutic Paradigm in organ-confined, muscle-invasive Urothelial carcinoma?

Information for

Open access

Opportunities

Help and information

Your download is now in progress and you may close this window

Login or register to access this feature

Does Perioperative Systemic Therapy Represent the Optimal Therapeutic Paradigm in organ-confined, muscle-invasive Urothelial carcinoma?

Financial & competing interests disclosure

Related research

To cite this article:

Download citation

Information for

Open access

Opportunities

Help and information

Keep up to date